Bachelors Degree in Organizational Behavioral Psychology with a background in Autism, Mental Health, Business Psychology
Moderna Vaccines for CoVid-19
Millions Skipping 2nd Dose of Vaccines Among Rising Concerns
Rebecca Robbins, New York Times, published an article on 25 April 2021 regarding the concern that millions of Americans aren’t receiving their second dose of the CoVid-19 Vaccine. Specifically, Phizer and Moderna versions. The protocol is that after the 1st dose of Moderna; you receive a 2nd dose, 4 weeks later to ensure full effectiveness. With the Phizer vaccine, after the 1st dose, the 2nd is to be administered 3 weeks later.
Approximately 8% of all Americans who received dose one; failed to receive dose two.
Reasons emerging for this failure to follow up with government recommendations are due to:
- Rapid rising concern from American citizens in regards to the overall safety of coronavirus vaccines. They are wary of its overall effectiveness as well; causing less of an intensity to follow up.
- Difficulty has also arisen for anyone vaccinated with dose 1, to be able to receive their dose 2.
Reasons for Americans wariness or fear directed towards these vaccines are increasingly due to concern over adverse side effects. Another rising concern is the belief that after only one dose; they are fully protected and don’t need another one administered. Finally, the availability has become a concern as many who have gone to receive the necessary second dose were unable to get them due to lack of inventory. Appointments scheduled at places like Walgreens had over booked dose 1 and lacked sufficient quantity to also give dose 2. Cancellations, by places like Walgreens, are on the rise because of running out.
In addition, appointments booked for a second dose would be at a different location that the first one was administered, and lacked the same version at the second location. A patient receiving a Phizer would show to an appointment and only Moderna was available.
Many states have implemented plans or measures in order to keep this number more contained.
- Arkansas and Illinois assigned specific teams of individuals to send out reminder calls, SMS texts, as well as letters.
- Pennsylvania has their college campuses ensuring that each student, prior to leaving campus at end of term, will get dose 2 (even despite possibility dose 1 wasn’t even given.)
- South Carolina allocated several thousand doses to be set aside specifically for patients with overdue second dose inoculations.
Evidence reportedly found in trials; as well as real-world immunity campaigns, highlight the seriousness of skipping a dose.
- One inoculation triggers the weaker immune system
- Weakened immune systems lead to becoming more susceptible to dangerous virus variants.
- There is no available data to truly show how long only one dose remains effective.
- In the United States, only the Johnson & Johnson vaccine legally is given in one dose.
Conflicting information also is reported that this “extreme concern” over Americans lack of follow-up with the required second dose is not entirely transparent. Data shows that anyone vaccinated with the first dose; typically DOES return for the next one. 3/4 of adults are returning with a 93% follow through.
They explain that the mis-booking was a huge aspect of the actuality of those that did not receive that dose; NOT because they decided not to. It’s also noted that the Center of Disease Controk; otherwise termed as CDC, has very limited data on the effectiveness of the vaccine if the second dose isn’t received on the 4th week.
With already natural and educated concerns on the mass production and distribution of a vaccine that hasn’t been studied long term for effectiveness or side effects. Add on the growing global vaccination concerns very apparent all over any news outlet or social media. The limited or conflicting statements released to the American public, it’s only natural that fears would develop for good cause.
Addressing Americans Fears of Safety and Effectiveness
Recently the Johnson & Johnson vaccine was found to be linked to a rare and serious blood clotting side effect. 23 April 2021, government officials spoke out to recommend immediate release of the vaccine, back into circulation for inoculation despite this data and global rising concerns.
The Atlantic.com media site; published an article (opinion piece in reality-keep in perspective) regarding the “influence” of the like-minded ideas regarding vaccines and safety; termed “Anti-Vaxers.” The article starts with :
Life can go back to normal in the United States only if millions more Americans get vaccinated against COVID-19.
There are also reasons an individual forms a personal view on any given topic. Reasoning of the above quoted mentions “the problem” is the author believes that communication is built in such a manner in 2021, it is designed to “discourage” that. Below are the ideas that people like-minded as this author believe is the “truty.”
- Exploitation of the science uncertainty for political advantage.
- ”Wild” claims go viral.
- That incidents that arise like the temporary halting of the Johnson &Johnson vaccine gives “Anti-Vaxer’s” another platform to spread mis-information designed to influence public certainty in the vaccine.
This article is included because all sides of, yet again another vaccine controversy, points out that the group they are discussing didn’t look at the small amount of people who actually developed the rare side effect of blood clots.
Yet pointing to that point: the authors point of view doesn’t site data either. Instead the description dares too also be designed to sway and Influence portraying fact, while it’s not verifiable.
Never mind that experiencing a blood clot after receiving the J&J vaccine appears more unlikely than being struck by lightning.
Stockpile of Vaccines In the United States: AstraZeneca Covishield
CNN Reports Possible Release of a New Vaccine: AstraZeneca Distribution Globally
With reports of issues with the already three main existing vaccines in nationwide distributioñ; Phizer, J&J, and Moderna, news of a new vaccine surfaces to be distributed soon to other countries. AstraZeneca was announced on 26 April 2021, to soon be exported.
Jen Psaki divulged on Monday; April 25th, at a White House press briefing, the decisión of the American Government to make available the supply in the US of AstraZeneca and approved for use.
With this “struggle” being depicted by the government to inoculate the growing number of people unable or refusing a first or second dose, apparent lack of inventory, there comes to light a stockpile in the U.S. of tens of millions vaccines of AstraZeneca and not one dose has been used one one American.
Reason this vaccine isn’t being administered to the American people is simple; the FDA has not yet approved nor granted emergency use. This means it is not authorized to be dispensed in the United State. Psaki affirmed the FDA will perform a “quality review” before any exportation of the vaccine.
This brings even more questions to light. One being what country receives it? How is that determined? Why won’t they approve it for emergency use in the States but so confident it’s approved for export? Will the findings and statistical analysis of any study or review that’s done be made public in it’s entirety?
No information has currently been released as to who would get vaccines imported from the United States. Without even that information; it’s impossible to determine and validity to answers to any other question. The only aspect that’s reiterated has been that these tens of millions of vaccines will get a quality review and next approval by the FDA and within two months shipped to an unidentified country or countries.
Many countries have struggled to ramp up the production and distribution of a vaccine to administer to their people. Many have urged the U.S. President, Joe Biden, to start sharing what has admittedly been stockpiled. India was one such country.
India requested that the U.S. government even send raw materials to assist them in the ability to start their own production of “AstraZeneca Covishield” vaccine. However, as India is almost begging for assistance; wealthier nations already allegedly grabbing any current U.S. vaccine exports. Biden’s administration receives calls almost daily from the nations allies requesting need of assistance.
Mexico and Canada are two countries that received assistance And a portion of that supply. When the American government was questioned in regards to their acquiring shipments; it’s quoted that the government stated that the shipments if vaccines were a “loan.”
This circles back to the question how the process looks like. How they decide what country gets the surplus. And why is it all seemingly centered around the United States?
- WHO authorizes AstraZeneca COVID-19 vaccine for emergency use
The World Health Organization on Monday granted emergency authorization to the Oxford-AstraZeneca coronavirus vaccine.Why it matters: WHO's authorization "should trigger the delivery of hundreds of millions of doses to countries that have signed up f
- AstraZeneca vaccine: US to begin sharing coronavirus vaccine doses soon - CNNPolitics
Stockpiles and a surplus of an unapproved vaccine by the FDA, in US, called AstraZeneca Covishield Vaccine surfaces.
Nearly 8 percent of those who got initial Pfizer or Moderna shots missed their second doses. State officials want to prevent the numbers from rising.
- 2nd COVID-19 vaccine set for OK in US with panel endorsement
|Approval Date||Name Of Vaccine||Alleged Affectiveness||Dosage||Side Effects||Recommended||Any significant side effects?|
2 doses, 3 weeks apart
Headache, Fatigue, chills, muscle aches mostly after 2nd dose
16 years and older
anaphylaxis, Bells Palsy
Pain at injection site, headache and fatigue, muscle pain
18 years and older.
anaphylaxis, Bells Palsy
2 doses, 4 weeks apart
Fever, muscle aches, headaches lasting a few days. Effects worse after second dose.
Not yet available in US
Needs approval for emergency use by FDA
2 doses, 1 month apart
Injection site pain, fever, muscle aches, headache.
18 years and older.
A recent term of “vaccine diplomacy” has been at the center of this entire pandemic. It’s a very new issue that is seemingly controversia. Yet again; surrounding the United States. Biden administration officials limited this newfound diplomacy over “concerns“ of “unforeseen” factors. Hence, stockpiling a surplus of a vaccine not even FDA approved. One excuse used is the necessary surplus stockpiled for future “boosters.” They further are quoted as to saying, “diplomacy is limited because of the spread if virus variants.”
The United States is hoarding a vaccine they won’t even use on Americans. Vaccines that still require a further quality review only so the FDA Can approve it so it’s exported for OTHER countries to use on THEIR people. Why isn’t Moderna being stockpiled for future boosters or for virus variants?
Adding to the mass confusion swirling in any educated individuals head; they emphasized the most important reason is “uncertainty of what version is the most effective in children.” Hoarding a vaccine not one Americans been given? But the three that ARE being given is only to anyone OvER 16-18 years old. Children aren’t being vaccinated. You’d have to stockpoile and hoard from adult Americans the 3 versions being administered; and vaccinate the kids and study those effects. 54% of adult Americans received one dose. Running out of the approved versions and surplus and hoard of one we can’t use but keep because it’s detrimental?
In March, Joe Biden was also quoted saying “When discussing surplus we are going to share with the rest of the world....but only after we take care of our people first.”
Global implication from a lack of vaccine diplomacy is expected to possibly have extreme consequences on the United States. Already in countries like Russia and China; where vaccine distribution has zero political implications, has outpaced the U.S. in distribution. It’s already markedly showing apparent of expanding influence in places like Central Asia.
Rare Blood Clot Side Effect
- Scientists Find How AstraZeneca Vaccine Causes Clots
Researchers in Germany say they've found
This content reflects the personal opinions of the author. It is accurate and true to the best of the author’s knowledge and should not be substituted for impartial fact or advice in legal, political, or personal matters.
© 2021 Abigayle Malchow-Rourk